Postnatal Cytomegalovirus Exposure in Infants of Antiretroviral-Treated and Untreated HIV-Infected Mothers
Infectious Diseases in Obstetrics and Gynecology · 2014 · 2014 · 1-8
DOI: 10.1155/2014/989721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Diseases in Obstetrics and Gynecology, 2014. Verfasst von Sarah A Meyer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Children's Hospital Boston, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Breast Feeding. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
HIV-1 and CMV are important pathogens transmitted via breastfeeding. Furthermore, perinatal CMV transmission may impact growth and disease progression in HIV-exposed infants. Although maternal antiretroviral therapy reduces milk HIV-1 RNA load and postnatal transmission, its impact on milk CMV load is unclear. We examined the relationship between milk CMV and HIV-1 load (4–6 weeks postpartum) and the impact of antiretroviral treatment in 69 HIV-infected, lactating Malawian women and assessed the relationship between milk CMV load and postnatal growth in HIV-exposed, breastfed infants through six months of age. Despite an association between milk HIV-1 RNA and CMV DNA load (0.39 log 10 rise CMV load per log 10 rise HIV-1 RNA load, 95% CI 0.13–0.66), milk CMV load was similar in antiretroviral-treated and untreated women. Higher milk CMV load was associated with lower length-for-age (−0.53, 95% CI: −0.96, −0.10) and weight-for-age (−0.40, 95% CI: −0.67, −0.13) Z -score at six months in exposed, uninfected infants. As the impact of maternal antiretroviral therapy on the magnitude of postnatal CMV exposure may be limited, our findings of an inverse relationship between infant growth and milk CMV load highlight the importance of defining the role of perinatal CMV exposure on growth faltering of HIV-exposed infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Children's Hospital Boston, Boston, MA 02115, USA.
- Department of Epidemiology, UNC-Chapel Hill, Chapel Hill, NC 27599, USA.
- Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA.
- Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
- College of Medicine, University of Malawi, Blantyre, Malawi.
- Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Meyer, S. A., Westreich, D. J., Patel, E., Ehlinger, E. P., Kalilani, L., Lovingood, R. V., Denny, T. N., Swamy, G. K., & Permar, S. R. (2014). Postnatal Cytomegalovirus Exposure in Infants of Antiretroviral-Treated and Untreated HIV-Infected Mothers. Infectious Diseases in Obstetrics and Gynecology, 2014, 1-8. https://doi.org/10.1155/2014/989721
Vancouver
Meyer SA, Westreich DJ, Patel E, Ehlinger EP, Kalilani L, Lovingood RV, et al. Postnatal Cytomegalovirus Exposure in Infants of Antiretroviral-Treated and Untreated HIV-Infected Mothers. Infectious Diseases in Obstetrics and Gynecology. 2014;2014:1-8. doi:10.1155/2014/989721
BibTeX
@article{Meyer2014,
author = {Meyer, Sarah A and Westreich, Daniel J and Patel, Emily and Ehlinger, Elizabeth P and Kalilani, Linda and Lovingood, Rachel V and Denny, Thomas N and Swamy, Geeta K and Permar, Sallie R},
title = {Postnatal Cytomegalovirus Exposure in Infants of Antiretroviral-Treated and Untreated HIV-Infected Mothers},
journal = {Infectious Diseases in Obstetrics and Gynecology},
year = {2014},
volume = {2014},
pages = {1--8},
doi = {10.1155/2014/989721}
}
EUVIMED